These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 9547117)

  • 1. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.
    Mittmann N; Herrmann N; Einarson TR; Busto UE; Lanctôt KL; Liu BA; Shulman KI; Silver IL; Narango CA; Shear NH
    J Affect Disord; 1997 Dec; 46(3):191-217. PubMed ID: 9547117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analytical studies on new antidepressants.
    Anderson IM
    Br Med Bull; 2001; 57():161-78. PubMed ID: 11719915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the placebo be the cure?
    Enserink M
    Science; 1999 Apr; 284(5412):238-40. PubMed ID: 10232967
    [No Abstract]   [Full Text] [Related]  

  • 8. Moclobemide. An update of its pharmacological properties and therapeutic use.
    Fulton B; Benfield P
    Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of treatment of depression.
    Broquet KE
    South Med J; 1999 Sep; 92(9):846-56. PubMed ID: 10498158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of antidepressants in the elderly.
    Sommer BR; Fenn H; Pompei P; DeBattista C; Lembke A; Wang P; Flores B
    Expert Opin Drug Saf; 2003 Jul; 2(4):367-83. PubMed ID: 12904093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials.
    Keller MB
    J Clin Psychiatry; 2000 Dec; 61(12):896-908. PubMed ID: 11206593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of newer medications for treating depression in primary care patients.
    Mulrow CD; Williams JW; Chiquette E; Aguilar C; Hitchcock-Noel P; Lee S; Cornell J; Stamm K
    Am J Med; 2000 Jan; 108(1):54-64. PubMed ID: 11059441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.
    Mills KA; Greene MC; Dezube R; Goodson C; Karmarkar T; Pontone GM
    Int J Geriatr Psychiatry; 2018 Apr; 33(4):642-651. PubMed ID: 29235150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.
    Smith D; Dempster C; Glanville J; Freemantle N; Anderson I
    Br J Psychiatry; 2002 May; 180():396-404. PubMed ID: 11983635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of antidepressants in elderly depressed outpatients: a prospective case series study.
    Mittmann N; Herrmann N; Shulman KI; Silver IL; Busto UE; Borden EK; Naranjo CA; Shear NH
    J Clin Psychiatry; 1999 Oct; 60(10):690-7. PubMed ID: 10549686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study.
    Parker G; Roy K; Wilhelm K; Mitchell P
    J Clin Psychiatry; 2001 Feb; 62(2):117-25. PubMed ID: 11247097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems with currently available antidepressants.
    Gumnick JF; Nemeroff CB
    J Clin Psychiatry; 2000; 61 Suppl 10():5-15. PubMed ID: 10910012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
    MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
    BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
    Williams JW; Mulrow CD; Chiquette E; Noël PH; Aguilar C; Cornell J
    Ann Intern Med; 2000 May; 132(9):743-56. PubMed ID: 10787370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.